Cargando…
New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities
Venous thromboembolism (VTE) is a major cause of morbidity, mortality, and healthcare expenditure. In the United States, approximately 0.1 % of the population experiences an initial VTE event each year. Anticoagulation therapy is the cornerstone of acute VTE treatment and for prevention of recurrent...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224738/ https://www.ncbi.nlm.nih.gov/pubmed/25300410 http://dx.doi.org/10.1007/s40265-014-0301-x |